Screening cognition in the elderly with metabolic syndrome

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 5, 2012, Pages 358-362

  Viscogliosi, Giovanni ^a   Andreozzi, Paola ^a   Chiriac, Iulia Maria ^a   Cipriani, Elisa ^a   Servello, Adriana ^a   Ettorre, Evaristo ^a   Marigliano, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COGNITION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SCORING SYSTEM; SCREENING; TRIACYLGLYCEROL BLOOD LEVEL;

AGE OF ONSET; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; RISK FACTORS; TRIGLYCERIDES;

EID: 84872870341     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2012.0043     Document Type: Article

References (21)

1. Grundy SM, Hansen B, Smith SC Jr, et al. American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of metabolic syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004;109:551-556.
2. The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
3. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-1062.
4. Ford E, Giles W, Dietz W. Prevalence of the metabolic syndrome among U.S. adults: Findings from the third national health and nutrition examination survey. JAMA 2002;287: 356-359.
5. Peterson MJ, Morey MC, Giuliani C, et al. Health ABC Study. Walking in old age and development of metabolic syndrome: The Health, Aging, and Body Composition Study. Metab Syndr Relat Disord 2010;8:317-322.
6. Cavalieri M, Ropele S, Petrovic K. Metabolic syndrome, brain magnetic resonance imaging, and cognition. Diabetes Care, 2010;33:2489-2495.
7. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292:2237-2242.
8. Roberts RO, Geda YE, Knopman DS, et al. Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: A population-based study. Alzheimer Dis Assoc Disord 2010;24:11-18.
9. Oguro H, Kobayashi S, Yamaguchi S. The association of metabolic syndrome with executive dysfunction independent of subclinical ischemic brain lesions in Japanese adults. Dement Geriatr Cogn Disord 2010;30:479-485.
10. Segura B, Jurado MA, Freixenet N, et al. White matter fractional anisotropy is related to processing speed in metabolic syndrome patients: A case control study. BMC Neurol 2010;10:64.
11. Tournoy J, Lee DM, Pendleton N, et al. EMAS study group. Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: The European Male Ageing Study. Diabetes Metab Res Rev 2010;26:668.
12. Solfrizzi V, Scafato E, Capurso C, et al. Italian Longitudinal Study on Aging Working Group. Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol Aging 2011; 32:1932-1941.
13. Hassenstab JJ, Sweat V, Bruehl H, et al. Metabolic syndrome is associated with learning and recall impairment in middle age. Dement Geriatr Cogn Disord 2010;29:356-362.
14. Saczynski JS, Jonsdottir MK, Garcia ME, et al. Cognitive impairment: an increasingly important complication of type 2 diabetes: The age, gene/environment susceptibility-Reykjavik study. Am J Epidemiol 2008;168:1132-1139.
15. Isik AT, Cankurtaran M, Bozoglu E, et al. Is there any relation between insulin resistance and cognitive function in the elderly? Int Psychogeriatr 2007;19:745-756.
16. Okereke OI, Kang JH, Cook NR, et al. Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults. J Am Geriatr Soc 2008; 56: 1028-1036.
17. Komulainen P, Lakka TA, Kivipelto M, et al. Metabolic syndrome and cognitive function: A population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 2007;23:29-34.
18. Lee KS, Jang Y, Chung YK, et al. Relationship between the diagnostic components of metabolic syndrome (MS) and cognition by ApoE genotype in the elderly. Arch Gerontol Geriatr 2010;50:69-72.
19. Grassi D, Ferri L, Cheli P, et al. Cognitive decline as a consequence of essential hypertension. Curr Pharm Des 2011;17:3032-3038.
20. Paran E, Anson O. The dynamics of blood pressure and cognitive functioning: results from 6-year follow-up of an elderly cohort. J Clin Hypertens (Greenwich) 2011;13: 813-817.
21. Hadjiev DI, Mineva PP. Antihypertensive treatment with cerebral hemodynamics monitoring by ultrasonography in elderly hypertensives without a history of stroke may prevent or slow down cognitive decline. A pending issue. Med Hypotheses 2011;76:434-437.